Transdermal Delivery of Arbutin Encapsulated by Ascorbyl Palmitate Liposomes

碩士 === 大同大學 === 生物工程學系(所) === 95 === The aim for the research is to encapsulate arbutin by liposome based on non-phospholipids “ascorbyl palmitate”, and then perform transdermal delivery experiments by adjusting different factors, such as different drug concentrations, encapsulating lipids, surfacta...

Full description

Bibliographic Details
Main Authors: Ci-Zong Zang, 臧其宗
Other Authors: Kow-Jen Duan
Format: Others
Language:zh-TW
Published: 2007
Online Access:http://ndltd.ncl.edu.tw/handle/u8j6z6
Description
Summary:碩士 === 大同大學 === 生物工程學系(所) === 95 === The aim for the research is to encapsulate arbutin by liposome based on non-phospholipids “ascorbyl palmitate”, and then perform transdermal delivery experiments by adjusting different factors, such as different drug concentrations, encapsulating lipids, surfactants etc. Furthermore, we got the physical data, such as permeability coefficients, skin-drug accumulation, and so on. From the result, we observed that the releasing rate of 5% arbutin liposome and 5% non-encapsulated arbutin solution are 19.60nmol/cm2/h and 14.79nmol/cm2/h respectively. It means the encapsulation of arbutin has enhancing effects for transdermal delivery. By adjusting different drug concentration, we observed that releasing rate rises with concentration under saturation concentration range. The best formulation is 5% arbutin and it comes to the number of 19.60nmol/cm2/h. By adjusting different surfactants, DA is the best formulation and it comes to 26.32 nmol/cm2/h. By adjusting different lipids, it showed that the lipid did not affect the release. In conclusion, the non-phospholipids “ascorbyl palmitate” has effects in improving the transdermal delivery efficiency and we could also apply it to other drugs to investigate the behaviors for delivery in the future.